The healthcare field is witnessing a major shift in glucose treatment with the introduction of GLP-1 transdermal devices. These groundbreaking vehicles offer a likely simple alternative to injections for individuals dealing with diabetes mellitus type 2. By avoiding the necessity for frequent injections, GLP-1 adhesives promise to enhance individua